Nii Osae of Mindbeam AI Describes Project to Identify Promising New Treatments Artificial intelligence promises to reshape drug discovery, including by helping to identify safer options to common medications in a fraction of the time. Nii Osae, founder and CEO of Mindbeam AI, describes how AI models produced promising insights into pain-relief drug research at his firm.